Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress MDXHealth Q1 2026 Earnings EPS Miss Weighs on Shares as Company Navigates Diagnostic Market BKYI Q1 2026 Earnings Significant EPS Beat Amidst Ongoing Operational Challenges SCNX Q1 2026 Earnings Significant EPS Beat Despite Lack of Revenue CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances ALZN Q1 2026 Earnings Narrowing Losses Beat Estimates by 70